Page 2 - Jon Olav News Today

HBC is pleased to announce the online publication of its abstract titled “Antiproliferative activity of marine-derived oligopeptides combined with androgen...

HBC is pleased to announce the online publication of its abstract titled “Antiproliferative activity of marine-derived oligopeptides combined with androgen receptor inhibition in preclinical... | May 30, 2023

The first quarter of 2023 shows a very good development for HBC. Revenues came in at NOK 44m vs NOK 30m last year, a growth of 48 % YoY and 32 % QoQ. The underlying growth we are seeing is coming from... | May 12, 2023

Reference is made to the notice from Hofseth BioCare ASA for an annual general meeting to be held on 28 April 2023 . Torill Standal Eliassen, board member of the Company, has received proxies to... | April 28, 2023

Hofseth BioCare ASA held its Annual General Meeting on 28 April 2023. 253,351,609 shares, amounting to 64.13 per cent of the share capital, were represent in the meeting or by proxy. All proposals... | April 28, 2023

The Annual General Meeting of Hofseth BioCare ASA will be held at the companys premises at Kipervikgata 13, 6003 Ålesund, on 28 April 2023 at 13:00 CET. The notice of the Annual General... | June 19, 2023

The Annual General Meeting of Hofseth BioCare ASA will be held at the companys premises at Kipervikgata 13, 6003 Ålesund, on 28 April 2023 at 13:00 CET. The notice of the Annual General... | June 19, 2023

The Annual General Meeting of Hofseth BioCare ASA will be held at the company's premises at Kipervikgata 13, 6003 Ålesund, on 28 April 2023 at 13:00 CET. ...

The Board of Directors of Hofseth BioCare ASA has approved the financial statements for 2022 and the Company has today published the Annual Report and Sustainability Report for 2022. Please find... | March 31, 2023

Hofseth International AS ("HI"), a close associate of Hofseth Biocare ASA's (the "Company") board member Roger Hofseth, has notified the Company that HI...